Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues:
Obstructive sleep apnea (OSA)	$ 67,923	$ 180,623
Total revenues	67,923	180,623
Costs and expenses:
Costs of revenues	41,660	49,104
General and administrative	425,804	474,041
Depreciation and amortization	205	150
Total costs and expenses	467,669	523,295
Loss from operations	(399,746)	(342,672)
Other income (expense):
Interest expense	(328,015)	(432,126)
Legal settlement		(240,000)
Other expense
Other income		2,380
Total other income (expense)	(328,015)	(669,746)
Income taxes
Net loss	$ (727,761)	$ (1,012,418)
PER SHARE INFORMATION
Net Loss Per Common Share	$ (0.01)	$ (0.02)
Weighted Average Number of Common Shares Outstanding	66,690,545	64,285,907